Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Wilms tumors develop through two distinct karyotypic pathways.

Mattias Höglund1, David Gisselsson, Gunnar B Hansen

  • 1Department of Clinical Genetics, Lund University Hospital, SE-221 85 Lund, Sweden. mattias.hoglund@klingen.lu.se

Cancer Genetics and Cytogenetics
|March 26, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genomic Medicine Sweden: Advancing precision medicine at the national level.

Journal of internal medicine·2026
Same author

Proliferation- and cytotoxic immune signatures identify chemotherapy-responsive bladder tumors in a molecular subtype dependent manner.

NPJ precision oncology·2026
Same author

Human Allele Frequency Distributions Contradict Current Narratives of Imminent Danger From Genetically Targeted Bioweapons.

Health security·2026
Same author

Stage-Independent Real-Time Subtype Classification and Comprehensive Biopsy Profiling of Urothelial Carcinomas by the Lund Taxonomy System.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same author

Future-proofing medicine for a world of volatility, uncertainty, complexity, and ambiguity.

Academic medicine : journal of the Association of American Medical Colleges·2026
Same author

Re: Joshua J. Meeks. Urothelial Cancer: What Is the Role of Expression-based Subtypes to Guide Neoadjuvant Therapy in Muscle-invasive Bladder Cancer? Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2025.11.014.

European urology focus·2026

Wilms tumor (a type of embryonic neoplasm) evolves through a common karyotypic pathway, with specific chromosomal gains or losses occurring in a predictable order. This study reveals distinct cytogenetic pathways in tumor development.

Area of Science:

  • Oncology
  • Genetics
  • Developmental Biology

Background:

  • Wilms tumor is an embryonic neoplasm with diverse histologic patterns.
  • Cytogenetic studies reveal nonrandom chromosomal changes, including frequent trisomies for chromosomes 7, 8, and 12.
  • The karyotypic evolution of Wilms tumors remains poorly understood despite extensive cytogenetic data.

Purpose of the Study:

  • To analyze frequent chromosomal imbalances in 355 Wilms tumor karyotypes.
  • To determine the order of chromosomal imbalance appearance and identify distinct karyotypic pathways.
  • To elucidate the common mode of karyotypic evolution in Wilms tumors.

Main Methods:

  • Statistical analysis of 355 Wilms tumor karyotypes.
  • Identification and classification of frequent chromosomal imbalances (e.g., +1q, +6, +7q, +8, +12, +13, -11, -16).

Related Experiment Videos

  • Assessment of temporal order and pathways of cytogenetic alterations.

    • Main Results:

    • Identified frequent chromosomal imbalances including +1q, +6, +7q, +8, +12, +13, -11, and -16.
    • Established a common mode of karyotypic evolution for low- and high-complex Wilms tumors.
    • Demonstrated at least two distinct cytogenetic pathways (gain-dominated and loss-dominated) with no shared late imbalances.

    Conclusions:

    • Wilms tumor karyotypic evolution follows a major, common pathway.
    • Distinct cytogenetic pathways, characterized by gains or losses, contribute to tumor development.
    • Polyploidy is a rare feature in Wilms tumor karyotypic evolution.